medication trolley

7/24/2019 Medication Trolley

1/24

MEDICATION TROLLEY (WAD 2)

Bil Ubat Dos Indikasi Kontraindikasi1 Tab.

Acarbose

100mg

Initially 50 mg

daily, increase to

3 times daily upto 100 mg 3

times daily. Ma

!00 mg 3 times

daily

"on insulin

dependent diabetes

mellitus #"IDDM$%&en diet t&erapy is

insu'cient

"on insulin

dependent diabetes

mellitus #"IDDM$ in

combination %it&

eisting

con(entional oral

t&erapy %&ereglycaemic control is

inade)uate

*atients less t&an 1+

years, c&ronic intestinal

disorders associated%it& distinct

disturbances o

digestion and

absorption,

-onditions %&ic& may

deteriorate as a result o

increased intestinal gas

ormation, pregnancy,

lactation, se(ere renalimpairment

! Chloral

!"ra#e

$o"%&m

200g' ml

DU/ 0.5 2 1 g

#ma ! g$ %it&

plenty o %ater at

bedtime

*reoperati(e

sedation

ypersensiti(ity to

c&loral &ydrate products

-ardiac disease

epatic or renal

impairment

*regnancy 4breast

eeding

*orp&yria

astritis3 I* De+#rose

Ah!"ro&s

0, -'

ccording to t&e

needs o t&e

patient

6or parenteral

replenis&ment o

7uid and minimal

carbo&ydrate

calories as re)uired

by t&e clinical

condition o t&e

patient

*atients %it& anuria,

diabetic coma,

&yperglycaemia,

intracranial or

intraspinal

&aemorr&age, delirium

tremens in de&ydrated

patients and glucose2

galactose malabsorption

syndrome.

Do not administered

simultaneously %it&

blood t&roug& t&e same

inusion set because o

t&e possibility t&at

pseudoagglutination o

red cells may occur8 I* D%a/eam

10mg'2ml

9tatus

epilepticus, by

slo% I: 5210e(ery 10215

9tatus epilepticus

9keletal muscle

spasmniety disorders

;espiratory depression

cute pulmonary

insu'ciency9e(ere &epatic


2/24

minute #rate not

more t&an 5

mg


3/24

e(ery 328 &ours5 I*. D%go+%

0.mg' 2ml

;apid

digitilisation

DU/ 4 -I/D

o(er 10 years,

initially 0.?5 2 1.5mg, ollo%ed by

!50 mcg > &ourly

until digitilisation

is complete

eart ailure %it&

atrial @brillation

9upra(entricular

arr&yt&mias

#particularly atrial@brillation$

:entricular @brillation,

(entricular tac&ycardia

ecept in certain cases,

digitalis toicity, beriberi

&eart disease,&ypersensiti(ity to

digoin, some cases o

&ypersensiti(e carotid

sinus syndrome

> I*.

Dobam%e

20mg'2ml

Initial 0.521

mcg


4/24

c&loride and

detrose inection

or 5C detrose I:

inusion,

ypertension o

pregnancyA !0mgper &our doubled

e(ery 30 min to

ma 1>0 mg per

&our I*

L%goca%e

100mg'ml

/ocal

anest&esia

DU/ Maimum

!00 mgA -I/D

Maimum 30

mg


5/24

I:. Ma !00 F 300

mg< &our

-I/D 0.+ F 1

mg

&our and t&enollo%ed by an oral

9e(ere nausea and

(omiting

:ertigo < labyrint&ine

disorder

-"9 depression or coma

Bone marro% depression

*&aeoc&romocytoma

ypersensiti(ity to

p&enot&ia=ines


6/24

dose.

"ot recommended in

c&ildren

-omatose states

-ardio(ascular collapse

1> Ra%#%"%e

0mg' 2ml

%*ec#%o

1$ DU/ slo% I:

inection o 50mg

diluted to !0ml andgi(en o(er at least

! minutes. Maybe

repeated e(ery >2+

&ours or I: inusion

at rate o !5

mg2+ &ours inter(als

or IM

-I/D 1mg &ours as re)uired

Ma 8 g daily

Use in c&ildren notrecommended

Mild to moderate

pain

astric and duodenal

ulcers

aemorr&agic diat&esis

ypersensiti(ity toaspirin or ot&er "9IDs

-&ildren under 1! years

old

ypersensiti(ity #attack

o ast&ma, angioedema,

urticaria or r&itinis$

*regnancy # t&ird

trimester$

*atient %it& &aemop&ilia

or &aemorr&agicdisorder

out


7/24

9e(ere renal or &epatic

impairment

lactation1 !osc%e N

3!lbrom%"

e 10 mgTable# (B)

rade "ame

Buscopan

DU/ 102!0 mg 328

times daily.

-I/D >21! years

10 mg 3 times

daily

astrointestinal

tract and genito2

urinary tract spasm,dyskinesia o t&e

biliary system

Gbstructi(e disease o

t&e gastrointestinal or

urinary tract, narro%2angle glaucoma, cardiac

tac&yarr&yt&mias,

myast&enia gra(is,

prostatic &ypertrop&y

%it& urinary retention!0 Ib&ro7e

200 mg

Table# (B)

rade "ame

Bruen

DU/ !00 2 800

mg 3 times daily

ater ood,

maimum. !.8 g

daily -I/D !0230 mg


8/24

!0 mgA -I/D less

t&an 15 years

0.1! mg

times a day beore

meals.

-I/D o(er > years

one tablet to be

taken 328 times a

day

eartburn,

dyspepsia

ypersensiti(ity to

antacids,

&ypop&osp&ataemia

!8 4rolase

Table#( B$

rade "ame

*apase

! tablet 8 times

daily

Gedema and

in7ammation in

conunction %it&

ot&er p&ysical or

c&emot&erapeutic

measures

Blood clotting disease.

!5 4rochlorera

/%e Malea#e

mg Table#

(B$rade "ame

9temetil

Inection IM 1!.5 mg

stat and repeated

i necessary ater >

&ours

or

orally !0 mg stat

ollo%ed by 10 mg

ater ! &ours.

*re(ention 5 2 10

mg ! 2 3 times a

day.

-I/D #o(er 10 kg

only$ !50 mcg


9/24

se(eral %eeks to 5

2 10mg daily. "ot

recommended in

c&ildren

increased risk o

etrapyramidal

reactions

!> 4arace#amol00 mg

Table# (-$

rade "ame

*anadol

DU/ 500 2 1000mg e(ery 8 2 >

&ours, maimum o

8 g daily

Mild to moderatepain and pyreia

"ep&ropat&y

!? Tr%rol%"%e

Cl 2. mg

a"

4se&"oehe

"r%e Cl 80mg Table#

(B $

rade "ame

ctied

DU/ !.5 mg e(ery

8 2 > &oursA

maimum dose 10

mg 2 1! years

1.!5 mg e(ery 8 2

> &oursA maimum

dose 5 mg!5

mg e(ery 8 2 >

&oursA maimum

dose !.5 mg years 0.3+

mg e(ery 8 2 >

&oursA maimum

dose 3.?88

mg &oursA maimum

dose 1.!5 mg


10/24

mg


11/24

minutes beore

surgeryA

E/DE;/J 1 2 1.5

mg


12/24

patients, 80mg

e(ery !8 &ours or

at least > days

until patient

ambulant, ma 18

days.reatment o D: or

pulmonary

embolism, 1.5

mg


13/24

I patient needs to

undergo *-I,

unractionated

&eparin to be

admin as per local

practice protocol,taking into account

t&e patientOs

bleeding risk and

time o last dose o

ondaparinu.

6ondaparinu may

be restarted no

earlier t&an ! &r

ater s&eat&

remo(al. iii$ DU/ more t&an

1+ years !.5 mg

once dailyA @rst

dose to be gi(en I:

#directly t&roug&

an eisting I: line

or as inusion in !5

or 50 ml o 0.C

saline o(er 12!

min$, subse)uentdoses to be gi(en

9-. reatment to

be initiated as

soon as diagnosis

is made and

continued up to a

ma o + days or

until &ospital

disc&arge,

%&ic&e(er comesearlier. I patient

needs to undergo

non2primary *-I,

unractionated

&eparin to be

admin as per local

practice protocol,

taking into account

t&e patientOs

bleeding risk andtime o last dose o

segment ele(ation

myocardial inarction

#9EMI$ in patients

managed %it&

t&rombolytics or are

not recei(ing ot&erorms o reperusion

t&erapy


14/24

ondaparinu.

6ondaparinu may

be restarted no

earlier t&an 3 &r

ater s&eat&

remo(al35 :l!cer!l

Tr%%#ra#e 0

mg'10 ml

I*ec#%o

;:l!cer!l

Tr%%#ra#e 2

mg' ml

I*ec#%o

Initial 5 mcg


15/24

single 8 mg once

B* acceptability

&as been

demonstrated. 8

mg once daily or !

%eeks, may beincreased to + mg

once daily.

E/DE;/J ! mg once

daily or 1 %eek,

t&en 8 mg once

daily or t&e

ollo%ing %eek,

may be increased

up to + mg once

daily3 4o#ass%&m

Chlor%"e

($lo-


16/24

e(ery > 2 + &ours

or as a single daily8! Ra%#%"%e

(=a#ac)

10mg Tab

150 mg t%ice daily

#at morning and

nig&t$ or 300 mg

on nig&t or 82+%eeks.

Maintenance 1502

300 mg on nig&t

150 mg t%ice daily

or 300 mg on nig&t

or +21! %eeks

150 mg daily or

t%ice daily

i($ 150 mg and may

be increased asnecessary to >

g


17/24

&ours by 9-

inection.

s or unstable

angina and acute

perip&eral arterial

occlusion. *rop&ylais in

general surgery, by

9- inection, 5000

units ! &our beore

surgery, t&en

e(ery +21! &ours

or ? days or until

patient is

ambulant, during

pregnancy #%it&monitoring$, 50002

10000 units e(ery

1! &ours. n

adusted dose

regimen may be

used or maor

ort&opaedic

surgery or lo%

molecular %eig&t

&eparin may beselected

85 Wa#er 7or

I*ec#%o

ccording to t&e

needs o t&e

patient

s a diluent and

(e&icle or t&e

administration o

medications

"ot kno%n

8> Is&l%

Recomb%a

# $!#he#%c

&ma>

%#erme"%a#eac#%g 100

I?'ml 4e@ll

a" Re@ll 3

(Is&la#ar")

Dose to be

indi(idualised.

&e a(erage daily

insulin re)uirement

is bet%een 0.521.0units


18/24

8? A&gme#%

1.2g I*

#moicillin

1g 4

-la(ulanate

!00mg In$(broad-

spectrum

anti-infective)

P 3 bln 30mg2+ &rly

Qangkitan

susceptible

organism pada

saluran respiratori,

kulit, tisu lembut,

U9epticaemia,

peritonitis,

osteomyelitis, post2

operati(e inection

ypersensiti(ity

ter&adap penicillin

9eara& penicillin2

associated c&olestatic

aundice

9eara& disungsi &epar

8+ 3e/!le%c%

ll% mega

&%#s (6g) I*

#narrow-

spectrum

anti-infective

*eads 50 F

100mg00 F

1!00mg IM )id, R?.!g daily in >

di(ided doses by

slo% I: inusion

Inecti(e

endocarditis

Qangkitan ole&

susceptible

organism

#Neisseriagonorrhoea, Corynebacterium

diphtheriae, Bacillus

anthracis, Clostridia,

Actinomycesbovis,S

treptobacillusmonili

formis, Listeriamon

ocytogenes,and Lept

ospiraA reponemap

allidum)

9eara& anap&ylais,

&ypersensiti(ity

ter&adap penicillin

8 Calc%&m:l&coa#e

10, I*

#Calcium)

*eads 50mg


19/24

inter(als$

9urgical prop&ylais

1 g I: 0.5 F ! &r

prior procedure51 Ce7&ro+%me

so"%&m0mg I*

(broad-

spectrum

anti-infective)

*eads 30 F 100

mg


20/24

3$55 9r&sem%"e

20mg'2ml %*

#"iuretic)

*eads 0.5 F

1.5mg am

Mera%at keradangan

#in7amasi$ seperti

dalam kes

o llergic reaction

o rt&ritis

o *enyakit

autoimmune#penyakit dara&,

kanser$o st&ma

2 1! years 10 ml 3

times daily. o be

taken %ell diluted

%it& %ater

6or systemic or urine

alkalinisation

9e(ere renal impairment

%it& oliguria, a=otemia

or anuria, ddisonOs

disease, adynamicepisodica &ereditaria,

acute de&ydration, &eat

cramps, se(ere

myocardial damage,

potassium citrate in

patients %it&

&yperkalemia, sodium

citrate or patients on

sodium restriction

>! Mages%&m

Tr%s%l%ca#e

102!0 ml 328 times eartburn,

dyspepsia

cute surgical abdomen,

&ypersensiti(ity to


22/24

M%+#&re daily beore meals antacids,

&ypop&osp&ataemia

>3 Oral

Reh!"ra#%o

$al#

DU/ !00 2 800 ml

# 1 2 ! sac&ets $ or

e(ery loosemotion.

-I/D !00 ml #1

sac&et$ or e(ery

loose motion. In

se(ere de&ydration

100 ml8 4o#ass%&m

Chlor%"e 1

g'10 ml

I*ec#%o

By slo% I: inusion

depending on t&e

de@cit or t&e daily

maintenance

re)uirements. 1 g

diluted in 500 ml

normal saline or

glucose and gi(enslo%ly o(er ! 2 3

&ours

6or t&e correction o

se(ere

&ypokalaemia and

%&en su'cient

potassium cannot be

taken by mout&

cute de&ydration, &eat

cramps, &yperkalaemia,

renal ailure and in

conditions in %&ic&

potassium retention is

present or %&ere

additi(es o potassium

and c&loride could beclinically detrimental

>5 Lac#&lose6.6 g' mlL%B&%" B

rade "ame

Dup&alac

DU/ 15 ml t%ice

daily adusted to

patientOs need.

-I/D 0.5

ml


23/24

EMER:ENCY TROLLEY (WAD 2)

Bi

l

Ubat

1 A"real%e 1mg'ml I*.! Am%oh!ll%e 20mg'

10ml I*.3 A#ro%e $&lha#e 1mg'ml

I*.8 Calc%&m :l&coa#e 1g'10

ml I*.5 Chlorhe%ram%e 10mg'ml

I*.> De+ame#hasoe5mg'2ml

I*.? De+#rose 0, -' I*+ D%go+% 0. mg'2ml I Dobam%e 20mg'20ml

I*.1

0

Doam%e 0mg'ml I*.

1

1

9l&ma/e%l 0.mg'ml I*.

1

!

9r&sem%"e 20mg'2ml I*.

13

:l!cer!l Tr%%#ra#e 0.mgTab.

1

8

:l!cer!l Tr%%#ra#e 0mg'

10ml I*.1

5

!"rocor#%soe 100mg I*.

1

>

Labe#alol 2mg'ml I*.

1

?

L%goca%e Cl 100mg'ml

I*.1

+

Nalo+oe Cl 0.mg'ml

(A"&l#) I*.1

Nora"real%e mg'ml I*.

!

0

4he!#o% $o"%&m

20mg'ml I*.!

1

4rome#ha/%e 0mg'2ml

I*.!

!

$o"%&m 3%carboa#e 5.,

I*.!

3

Terbal%e $&lha#e

2.mg'ml I*.! eraam%l mg'2ml I*.


24/24

8!

5

Wa#er 7or I*ec#%o 10ml

medication trolley

Documents